Amy Kramer
Abramson Cancer Center · 10 works · 1,140 citations · h-index 7
Top works
- Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody
- Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
- Preliminary results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma
- Updated results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma
- Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
- Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors
- A phase II trial of gefitinib in combination with 5-FU/LV/irinotecan in patients with colorectal cancer
- Abstract 2521: Combining chemotherapy with autophagy inhibition: Phase I trial of dose-intense temozolomide and hydroxchloroquine in patients with advanced solid tumors
- Abstract PR7: Clonal profiling of prospectively collected primary pancreatic ductal adenocarcinomas.
- Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes.